Suzhou Leadsynbio Technology Co.,Ltd. Leadsynbio logo

News | Leadsynbio achieves dual compliance with Self-GRAS and NDI

News | Leadsynbio achieves dual compliance with Self-GRAS and NDI

Recently, Leadsynbio’s microbially fermentation-based β-nicotinamide mononucleotide (NMN) reached another core U.S. market compliance milestone, officially receiving a New Dietary Ingredient (NDI) No Objection Letter from the U.S. FDA, with NDIN No. 1497.

[ Details ]Nov 16,2026
Market | Leadsynbio showcased green manufacturing practices at API China 2026

Market | Leadsynbio showcased green manufacturing practices at API China 2026

On November 11,Leadsynbio showcased our core products and new product plans at API China 2026, engaging with customers and industry experts to discuss technology frontiers and innovative applications, and to explore pathways for sustainable industrydevelopment.

[ Details ]Nov 16,2026
Market | Leadsynbio shines at CPHI Milan 2026, connecting the world through green biomanufacturing

Market | Leadsynbio shines at CPHI Milan 2026, connecting the world through green biomanufacturing

CPHI Milan 2026, the world's leading pharmaceutical ingredients exhibition, was held in Milan, Italy, from October 6 to 8. Leadsynbio took part, connecting with customers and partners from Europe and around the world to discuss green biomanufacturing, stable supply, and long-term collaboration.

[ Details ]Oct 12,2026
News | Leadsynbio completes RMB 450 million Pre-IPO financing to accelerate new product industrialization and market expansion

News | Leadsynbio completes RMB 450 million Pre-IPO financing to accelerate new product industrialization and market expansion

Recently, Leadsynbio completed a RMB 450 million Pre-IPO financing round.

[ Details ]Sep 30,2026
News | Leadsynbio's fermentation-produced NMN achieves Self-GRAS status, securing compliant access to the U.S. market

News | Leadsynbio's fermentation-produced NMN achieves Self-GRAS status, securing compliant access to the U.S. market

Recently, Leadsynbio’s microbial-fermentation-produced NMN has officially passed the authentication of U.S. Self-GRAS. This signifies that our NMN can be sold and used as a safe and compliant food ingredient in the U.S. market, providing crucial supportfor Leadsynbio’s global expansion.

[ Details ]Sep 03,2026
Market | Leadsynbio showcased at the World Natural Health Ingredients Expo 2026

Market | Leadsynbio showcased at the World Natural Health Ingredients Expo 2026

From August 24 to 26, 2026, Leadsynbio made a strong presence at the 6th World Natural & Health Ingredients Expo (WPE&WHPE 2026), engaging in in-depth exchanges with industry partners and clientson topics ranging from natural health ingredients to broader collaboration opportunities.

[ Details ]Aug 28,2026
NMN & Hair health: Resent research review

NMN & Hair health: Resent research review

Stress, hormonal shifts, and late nights are taking a toll on hair health, especially among the young. Androgenetic alopecia only adds to the challenge. Yet amid the search for solutions, NMN has evolved from a mere clue into an evidence-backed answer.

[ Details ]Aug 12,2026
News | Leadsynbio was featured on Suzhou News, showcasing our biomanufacturing lab

News | Leadsynbio was featured on Suzhou News, showcasing our biomanufacturing lab

Leadsynbio was recently featured on Suzhou News. The segment will take you inside our biomanufacturing lab, offering a firsthand look at our development and deployment of synthetic biology.

[ Details ]Aug 11,2026
News | Leadsynbio took part in State Science and Technology Award‑winning project

News | Leadsynbio took part in State Science and Technology Award‑winning project

Recently, theproject in which Leadsynbio participated was awarded the Second Prize of the 2025 State Scientific and Technological Progress Award.

[ Details ]Jul 14,2026
Market | Anhui Liberty Showcased at China Veterinary Drug Conference and Exhibition 2026

Market | Anhui Liberty Showcased at China Veterinary Drug Conference and Exhibition 2026

On June 18–19, China Veterinary Drug Conference and Exhibition 2026 was held at the Hefei Binhu International Convention and Exhibition Center. Anhui Liberty Pharmaceutical Co., Ltd., a wholly‑owned subsidiary of Leadsynbio, joined the provincial delegationas a representative of outstanding animal health enterprises from Anhui, engaging with industry peers to explore new dynamics in the sector.

[ Details ]Jun 22,2026
Prev 1 2 3 4 .... 11 Next

Recommended news

Contact us

  • 4-5th Floor, Building C11, Biomedical Industrial Park, NO. 218 Xinghu Street, Suzhou Industrial Park, Suzhou, Jiangsu
  • service@leadsynbio.com
  • 0512-62955029
  • 0512-62955029
Suzhou Leadsynbio Technology Co.,Ltd.©Copyright